mild to moderate COVID-19
Showing 1 - 25 of >10,000
Infection of Upper Respiratory Tract Caused by 2019-nCoV Trial in Shanghai (SA55 Injection)
Recruiting
- Infection of Upper Respiratory Tract Caused by 2019-nCoV
- SA55 Injection
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 12, 2023
Coronavirus Infections, Pneumonia, Viral, Acute Respiratory Distress Syndrome Trial in Anchorage, Shreveport, Boston (Nitric
Active, not recruiting
- Coronavirus Infections
- +2 more
- Nitric Oxide
-
Anchorage, Alaska
- +2 more
Oct 31, 2022
Covid19 Trial in Klerksdorp (Triazavirin (Riamilovir), Placebo)
Terminated
- Covid19
- Triazavirin (Riamilovir)
- Placebo
-
Klerksdorp, North West Province, South AfricaThe Perinatal HIV Research Unit - Matlosana
Jul 29, 2022
COVID 19 Disease, Mild to Moderate COVID 19 Disease, SARS-CoV-2 Trial (Tafenoquine Oral Tablet, Placebo)
Not yet recruiting
- COVID 19 Disease
- +4 more
- Tafenoquine Oral Tablet
- Placebo
- (no location specified)
Jul 13, 2023
COVID-19 Trial in Guangzhou (SHEN26 capsule, SHEN26 )
Recruiting
- COVID-19
- SHEN26 capsule
- SHEN26 placebo
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital Of Guangzhou Medical University
Jun 19, 2023
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial (MBS-COV, Placebo)
Not yet recruiting
- Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
- MBS-COV
- Placebo
- (no location specified)
Jul 11, 2023
COVID-19 Trial in Jinan (QLS1128, Placebo)
Not yet recruiting
- COVID-19
- QLS1128
- Placebo
-
Jinan, Shandong, ChinaQilu Pharmaceutical Co., Ltd.
Mar 8, 2023
Mild to Moderate COVID-19 Trial in Shenzhen (FB2001, FB2001 )
Recruiting
- Mild to Moderate COVID-19
- FB2001
- FB2001 placebo
-
Shenzhen, Guangdong, ChinaShenzhen Third People's Hospital
Jan 4, 2023
COVID-19 Pneumonia Trial (GST-HG171/Ritonavir, Placebo)
Not yet recruiting
- COVID-19 Pneumonia
- GST-HG171/Ritonavir
- Placebo
- (no location specified)
Dec 18, 2022
Cognitive Impairment and Fatigue After Mild to Moderate COVID-19
Recruiting
- Post COVID-19 Condition
- +2 more
- Neuropsychological investigation
- +3 more
-
Stockholm, SwedenDepartment of Rehabilitation Medicine, Danderyd Hospital
Sep 18, 2023
COVID-19 Trial in Jinan (QLS1128, Placebo)
Recruiting
- COVID-19
- QLS1128
- Placebo
-
Jinan, Shandong, ChinaQilu Pharmaceutical Co., Ltd.
Jan 15, 2023
Covid19 Trial in Montréal (Dalcetrapib, Placebo)
Completed
- Covid19
- Dalcetrapib
- Placebo
-
Montréal, Quebec, CanadaInstitut de Cardiologie de Montréal
Nov 10, 2022
COVID-19 Trial (Chinese Herb, Placebo)
Not yet recruiting
- COVID-19
- Chinese Herb
- Placebo
- (no location specified)
Mar 25, 2023
Covid19 Trial in Taunton (Hyperbaric Oxygen Therapy)
Completed
- Covid19
- Hyperbaric Oxygen Therapy
-
Taunton, MassachusettsMorton Hospital
Feb 1, 2023
COVID-19 Trial in Guangzhou, Shenzhen, Shijiazhuang (SHEN26 dose 1, SHEN26 dose 2, SHEN26 )
Recruiting
- COVID-19
- SHEN26 dose 1
- +2 more
-
Guangzhou, Guangdong, China
- +3 more
Jan 4, 2023
A Retrospective Study in Patients With Mild to Moderate COVID-19
Recruiting
- COVID-19
-
Shanghai, Shanghai, ChinaShanghai Pudong Hospital
May 13, 2022
COVID 19 Disease Trial in United States (Tafenoquine Oral Tablet, Placebo)
Completed
- COVID 19 Disease
- Tafenoquine Oral Tablet
- Placebo
-
Miami, Florida
- +9 more
Jan 13, 2023